Work

A phase I study targeting newly diagnosed glioblastoma with anti-CD3 × anti-EGFR bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide

Year: 2022

Type: conference-abstract

Source: WFNOS 2022 Abstract Book

DOI: 10.14791/btrt.2022.10.f-2596

Authors: Camilo Fadul, Jungeun Kim, Archana Thakur, Jessica Kassay-McAllister, Dana Schalk, Ewa kubicka, Benjamin Purow, Beatriz Lopes, David Schiff, Joseph Donahue, Patrick Dillon, Tri Le, Qin Liu, Lawrence Lum

Institutions: University of Virginia Health System, University of Virginia, University of Virginia Cancer Center, The Wistar Institute

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4293204367

Cites:

Cited by: 1

Related to: 10